A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer
Clinical trial NCT06485271 · RECRUITING
Trial details
- NCT number
- NCT06485271
- Sponsor
- Changzhi People's Hospital Affiliated to Changzhi Medical College
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-10-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.